Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025

Bulletin Express12-04

Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital remained unchanged from the preceding month.

The total authorized share capital stood at RMB 1,804,439,838, divided into 1,804,439,838 ordinary shares of RMB 1 par value each. At the close of November 2025, the issued number of ordinary H shares was 1,804,439,838 with zero treasury shares. No warrants, convertibles, or share options were issued or exercised during the period.

The confirmation provided in the announcement indicated compliance with relevant regulations and completion of all necessary procedural requirements. The document was submitted by Joint Company Secretary, Ms. Li Yunyi.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153046536?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153046536","market":"hk","top_or_hot":-1,"title":"Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025","media":"Bulletin Express","content":"<p>Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital remained unchanged from the preceding month.</p>\n<p>The total authorized share capital stood at RMB 1,804,439,838, divided into 1,804,439,838 ordinary shares of RMB 1 par value each. At the close of November 2025, the issued number of ordinary H shares was 1,804,439,838 with zero treasury shares. No warrants, convertibles, or share options were issued or exercised during the period.</p>\n<p>The confirmation provided in the announcement indicated compliance with relevant regulations and completion of all necessary procedural requirements. The document was submitted by Joint Company Secretary, Ms. Li Yunyi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLepu Biopharma (02157) Reports Unchanged Share Capital for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital remained unchanged from the preceding month.</p>\n<p>The total authorized share capital stood at RMB 1,804,439,838, divided into 1,804,439,838 ordinary shares of RMB 1 par value each. At the close of November 2025, the issued number of ordinary H shares was 1,804,439,838 with zero treasury shares. No warrants, convertibles, or share options were issued or exercised during the period.</p>\n<p>The confirmation provided in the announcement indicated compliance with relevant regulations and completion of all necessary procedural requirements. The document was submitted by Joint Company Secretary, Ms. Li Yunyi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"","article_id":"1153046536","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153046536","pubTimestamp":1764838419,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物(02157)2025年11月股本不变","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital remained unchanged from the preceding month.\nThe total authorized share capital stood at RMB 1,804,439,838, divided into 1,804,439,838 ordinary shares of RMB 1 par value each. At the close of November 2025, the issued number of ordinary H shares was 1,804,439,838 with zero treasury shares. No warrants, convertibles, or share options were issued or exercised during the period.\nThe confirmation provided in the announcement indicated compliance with relevant regulations and completion of all necessary procedural requirements. The document was submitted by Joint Company Secretary, Ms. Li Yunyi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153046536","isCrawlerRequest":true}